Innovating Works

H2020

Cerrada
HORIZON-EIC-2021-PATHFINDERCHALLENGES-01...
Emerging Technologies in Cell and Gene therapy
Scope:Cell and gene therapy (CGT) are widely accepted as top biomedical trends for over three years now and continue to evolve in their use for treating human diseases. CGTs are expected to increasingly shape the medical treatment and diagnosis, as we are approaching the era of precision medicine. Cell-based therapy is a promising strategy for effective treatment across a wide range of diseases though the focus so far, has primarily been on cancer, e.g. Chimeric Antigen Receptor T-cell (CAR-T) therapy made from removing T cells from individual patients, engineer them to be able to recognize and kill cancer cells before re-administer them to the same patient. CAR-T cell therapy is widely regarded as having revolutionised the treatment of some blood cancers. Recent research evidence suggests that cell therapy can effectively apply to solid cancers as well.
Sólo fondo perdido 100%
Europeo
Mostrando 1 al 20 de 136 resultados
ASTOUND: Improving social competences of virtual agents through artificial consciousness based on the Attenti... UNIVERSIDAD POLITÉCNICA DE MADRID tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-01 In the last decade, deep learning algorithms have enabled AI systems to perform a series of tasks, like speech and image recognition, as wel...
2022-12-14 - 2025-11-30 | Financiado
REFORM: PRINTED ELECTRONICS FOR THE CIRCULAR ECONOMY FUNDACION CIDETEC tramitó un HORIZON EUROPE: HORIZON-CL4-2021-DIGITAL-EMERGING-01-31 REFORM (pRinted Electronics FOR the circular econoMy) sets out to address the environmental and sustainability challenges around conventiona...
2022-12-07 - 2026-06-30 | Financiado
augMENTOR: Augmented Intelligence for Pedagogically Sustained Training and Education UNISYSTEMS LUXEMBOURG SARL tramitó un HORIZON EUROPE: HORIZON-CL2-2021-TRANSFORMATIONS-01-05 AUGMENTOR aims to develop a novel pedagogical framework that promotes both basic skills and 21st century competencies by integrating emergin...
2022-12-05 - 2025-12-31 | Financiado
ELOBIO: ELectrOlysis of BIOmass CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-04 The ELOBIO consortium aims at advancing biomass electrolysis as a novel technological mean of green H2 production. ELOBIO will demonstrate t...
2022-11-10 - 2026-12-31 | Financiado
VALAWAI: Value-Aware Artificial Intelligence AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-01 By Value-Aware AI we mean AI that includes a component performing the same function as human moral consciousness, namely the capacity to acq...
2022-11-02 - 2026-09-30 | Financiado
SUMO: Supervised morphogenesis in gastruloids The lack of realistic in vitro organ models that can faithfully represent in vivo physiological processes is a major obstacle affecting the...
2022-09-16 - 2027-10-31 | Financiado
CITRUS: Closed-loop Individualized image-guided Transcranial Ultrasonic Stimulation MEDIZINISCHE UNIVERSITAET WIEN tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-02 We are joining forces across Europe to advance a new non-invasive technology – transcranial ultrasound stimulation (TUS) – to reversibly mod...
2022-09-14 - 2026-09-30 | Financiado
EdiGenT: New Prime Editing and non-viral delivery strategies for Gene Therapy SORBONNE UNIVERSITE tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03 Genome editing technologies based on CRISPR/Cas systems allow targeted genomic modification with unprecedented precision and have emerged as...
2022-09-13 - 2027-09-30 | Financiado
FUROID: Up-scaled continuous production of artificial hair, fur and wool follicules using FUROID and HAROID... BIOFABICS LDA tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-05 The mission of FUROID is to enable animal-free production of hair (humans), fur (endangered animals) or wool (sheep). The key innovation is...
2022-09-12 - 2027-10-31 | Financiado
NOVISTEM: NOn-VIral gene modified STEM cell therapy UNIVERSITEIT GENT tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03 Despite the increasing awareness that cell and gene-therapy approaches have tremendous biomedical potential, their broad clinical applicatio...
2022-09-12 - 2026-10-31 | Financiado
PAT4CGT: Automated online monitoring & control to improve processes and decision making in cell and gene ther... DA VINCI LABS tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03 Problem: Cell and gene therapies (CGT) represent a breakthrough in the treatment of a wide range of conditions. However, limited global manu...
2022-09-12 - 2025-09-30 | Financiado
EDUCATE: EDUcation about ClimATE change and polar science TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-CITIZENS-01-01 Recent scientific reports of increasing global temperature, rising sea level trends, and atmospheric carbon dioxide levels clearly indicate...
2022-08-22 - 2023-05-31 | Financiado
HPNNING: Healthy Public eNgagemeNt IN Groningen - Chronically Healthy RIJKSUNIVERSITEIT GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-CITIZENS-01-01 Healthy Public eNgagemeNt IN Groningen - Chronically Healthy promotes science and scientists on public health in an interactive, accessible...
2022-07-29 - 2024-05-31 | Financiado
SESAM2030: SESAM2030 - science, citizens, schools and a hungry planet KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-CITIZENS-01-01 The climate crisis is obvious, the nature needs protection, biodiversity is under threat and the environment needs to be taken care of. But...
2022-07-25 - 2024-06-30 | Financiado
MICROVASC: Remote whole-brain functional microscopy of the vascular system: a paradigm shift for the monitoring... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-02 Obtaining functional information on living organs non-invasively across different size scales is a tremendous challenge in medical imaging r...
2022-07-11 - 2027-09-30 | Financiado
AAVolution: Next-generation AAV vectors for liver-directed gene therapy FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03 Liver-directed gene therapy has undergone significant development in the last two decades. Recombinant adeno-associated vectors (AAV) are th...
2022-07-11 - 2026-09-30 | Financiado
OHPERA: Optimised Halide Perovskite nanocrystalline based Electrolyser for clean, robust, efficient and dece... UNIVERSITAT JAUME I DE CASTELLÓ tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-04 Photoelectrochemical (PEC) H2 generation, using water as proton and electron source, is considered the most impactful solar-driven processes...
2022-07-11 - 2026-03-31 | Financiado
METATOOL: A metapredictive model of synthetic awareness for enabling tool invention UNIVERSIDAD POLITÉCNICA DE MADRID tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-01 Around 3.3 million years ago our ancestors made the first tool. They imagined a new utensil and then knapped a stone until it became an effi...
2022-07-08 - 2026-09-30 | Financiado
PhotoSynH2: Photosynthetic electron focusing technology for direct efficient biohydrogen production from solar e... AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-04 We propose a disruptive technology based on synthetic biology, we call photosynthetic electron focusing, for the efficient production of hyd...
2022-07-08 - 2027-09-30 | Financiado
CROSSBRAIN: Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic l... UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-02 A vast number of pathological brain conditions directly involve aberrant electrical activity of the brain. CROSSBRAIN centres its technologi...
2022-07-08 - 2026-10-31 | Financiado